✦ LIBER ✦

Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis

✍ Scribed by Michael D. Reed; Robert C. Stern; Joseph S. Bertino Jr.; Carolyn M. Myers; Toyoko S. Yamashita; Jeffrey L. Blumer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disposition of drugs in cystic fibrosis.

✍ Hutabarat, Renta M; Unadkat, Jashvant D; Sahajwalla, Chandrahas; McNamara, Sharo 📂 Article 📅 1991 🏛 Nature Publishing Group 🌐 English ⚖ 564 KB

Dosing implications of altered gentamici

✍ Gregory L. Kearns; Pharm D.; Bettina C. Hilman; John T. Wilson 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Oral Absorption of Trimethoprim-Sulfamet

✍ Dr. Michael E. Klepser; Ms. Zhu Zhu; Dr. David P. Nicolau; Ms. Mary Anné Banevic 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Characterization of sulfamethoxazole met

✍ A. Elsheikh; P. Whitaker; D. Peckham; B.K. Park; D.J. Naisbitt 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Lowering doses of pancreatic enzyme supp

✍ Maria R. Mascarenhas; Sonal Mehta; Maria Hanna; Dror Wasserman; William J. Wenne 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Duration of prophylaxis with trimethopri

✍ P. Malhotra, S. D. Rai, D. Hirschwerk 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 155 KB